Vincent Gardès

Vincent Gardès

Director Ejecutivo en Germitec SA .

Health Technology
Finance
Consumer Services

Perfil

Vincent Gardès currently works at Germitec SA, as Chief Executive Officer & Director from 2022, Amber Implants, as Executive Chairman from 2020, and Truffle Capital SAS, as Partner from 2018.
Mr. Gardès also formerly worked at Vexim SA, as Chief Executive Officer & Director from 2015 to 2018, Affluent Medical SA, as Chairman from 2018 to 2020, Théraclion SA, as Director, CR Bard (Spain), as Managing Director, Stryker Spine SAS, as Product Manager, Stryker Orthopaedics Corp., as Product Manager, Medtronic France SAS, as Manager-Business Unit from 2002 to 2007, and Stryker Spain Holding SL, as Manager-Sales & Marketing from 1996 to 1999.
Mr. Gardès received his undergraduate degree from Institut Des Etudes Economiques Et Commerciales.

Cargos activos de Vincent Gardès

EmpresasCargoInicio
Inversor de Capital Privado 01/09/2018
Presidente 01/12/2020
Director Ejecutivo 01/01/2022
Todos los cargos activos de Vincent Gardès

Antiguos cargos conocidos de Vincent Gardès.

EmpresasCargoFin
AFFLUENT MEDICAL Presidente 01/05/2020
VEXIM Director Ejecutivo 31/05/2018
Corporate Officer/Principal 01/09/2007
Corporate Officer/Principal 01/01/2002
Ventas & Marketing 01/01/1999
Ver el detalle de la experiencia de Vincent Gardès.

Formación de Vincent Gardès.

Institut Des Etudes Economiques Et Commerciales Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Vincent Gardès.

Relaciones

52

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
THERACLION

Health Technology

AFFLUENT MEDICAL

Health Technology

Empresas privadas9

Health Technology

Health Technology

Finance

Health Technology

Health Services

Health Technology

Finance

Health Technology

Health Technology

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA